ABSTRACT
PURPOSE: To compare the inhibitory effects of dovitinib and bevacizumab for treatment of corneal neovascularization (CNV). METHODS: Thirty-nine adult female Sprague Dawley rats weighing 180 to 250 g were used. CNV was induced by silver nitrate in the right eye of each rat. After the chemical burn, the animals were randomized into 5 groups. Group 1 did not receive any chemical substance. Group 2 received dimethyl sulfoxide, group 3 received bevacizumab 5 mg/mL, group 4 received dovitinib 5 mg/mL, and group 5 received bevacizumab 5 mg/mL + dovitinib 5 mg/mL topically administered twice daily for 14 days. On the 14th day, slit-lamp examination was performed, and anterior segment photographs were taken. The corneal neovascular area was measured on photographs as the percentage of the cornea's total area using computer imaging analysis. The corneal sections were stained with hematoxylin and eosin for histopathological examination. RESULTS: A statistically significant decrease in the percentage of CNV was found in all treatment groups (group 3, group 4, and group 5) compared with the control group (group 1) (P < 0.01). A statistically significant difference in the percentage of CNV was found among group 3, group 4, and group 5 (P = 0.003). The percentage of CNV in group 4 was significantly higher than that in group 3 and group 5 (P1 = 0.004; P2 = 0.006). There was no statistically significant difference in the percentage of CNV between group 3 and group 5 (P = 0.228). CONCLUSIONS: Dovitinib is a newly developed multitargeted tyrosine kinase inhibitor. Topical administration of dovitinib effectively inhibited CNV, but this effect of dovitinib was found less than topical bevacizumab.
Subject(s)
Benzimidazoles/therapeutic use , Bevacizumab/therapeutic use , Corneal Neovascularization/drug therapy , Quinolones/therapeutic use , Administration, Topical , Angiogenesis Inhibitors/therapeutic use , Animals , Burns, Chemical/drug therapy , Disease Models, Animal , Eye Burns/drug therapy , Female , Ophthalmic Solutions/administration & dosage , Rats , Rats, Sprague-Dawley , Vascular Endothelial Growth Factor A/antagonists & inhibitorsABSTRACT
PURPOSE: To assess and investigate the relationship between diurnal variations in intraocular pressure (IOP) and biomechanical properties of cornea. METHODS: Sixty-two healthy volunteers were recruited. Corneal compensated IOP (IOPcc), Goldmann-correlated IOP (IOPg), corneal resistance factor (CRF), and corneal hysteresis (CH) parameters were recorded by the Ocular Response Analyzer (ORA). Central corneal thickness (CCT) was measured using an ultrasonic pachymeter. Three consecutive measurements of IOPcc, IOPg, CRF, CH, and CCT were recorded at 8:00 am, 11:00 am, 2:00 pm, and 5:00 pm. One-way analysis of variance and Pearson correlation tests were used for statistical analysis. Intra device repeatability was evaluated using Scheffe multiple comparison. RESULTS: IOPcc, IOPg, CRF, CH, and CCT measurements displayed a stable profile during daytime acquisitions and no statistically significant variation was noted (p>0.05). All measurements of IOPcc, IOPg, CRF, and CH recorded by ORA at 8:00 am, 11:00 am, 2:00 pm, and 5:00 pm were all found to be highly repeatable (p>0.05). There was a statistically significant and inverse correlation between IOPcc and CH (p=0.001), and a positive correlation was detected between IOPcc and CRF (p=0.001). CRF and CH were both found to be positively correlated to CCT (p=0.001). CONCLUSIONS: IOPcc readings and recordings of corneal biomechanics were constant throughout the day in healthy eyes. CRF and CH seem to exert different effects on IOPcc as diverse correlations were detected between CRF, CH, and IOPcc. Assessment of IOP and corneal biomechanics using ORA was found to be a highly repeatable.
